Pfizer Ends Sangamo Alliance With Gene Therapy for Hemophilia on Cusp of FDA Filing
Posted:
Pfizer is walking away from partner Sangamo Therapeutics ahead of expected regulatory submissions for the hemophilia A gene therapy they co-developed. Cash-strapped Sangamo said it is now looking for a new partner for the program.
Read the full article in the latest MedCity News blog post here.
Procurement plays a critical role in the future of the NHS. As healthcare organisations face increasing financial pressures, rising demand, and the need to adopt innovative technologies, procurement professionals are central to delivering better value, improving patient outcomes, and supporting…
The NHS is under increasing pressure to deliver better outcomes while managing growing demand, workforce challenges, and limited resources. Innovation is no longer optional—it's essential.
That's why The Innovating NHS Systems Congress, part of GIANT Health Event 2026, brings together…
Attendees
Sponsors and Exhibitors
Contact us